SNDL launches cannabis review and proposes CAD 50 million bid for SNDL stock

Published on 10/27/2026 at 14:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

SNDL posted record CAD 20.0 million free cash flow in Q3 2026. SNDL stock costs EUR 1.15 on October 27, 2026 at USD 312.6 million market value.

Strategic review and operating reset

SNDL reported CAD 238.0 million in third-quarter revenue on October 27, 2026.
Adjusted operating income reached CAD 5.2 million in the third quarter of 2026.
SNDL stock trades at EUR 1.15 at 2:17 p.m. CEST at Lang & Schwarz on October 27, 2026.
TipRanks lists a USD 3.50 price target and Buy rating on October 27, 2026.

SNDL, CA83307B1013, Illustration mit AI erstellt.

SNDL (ISIN CA83307B1013) reported record free cash flow of CAD 20.0 million for the third quarter of 2026, while revenue fell 2.5 percent year over year to CAD 238.0 million. The results dated October 27, 2026 also launched a strategic review of the company's Cannabis Operations segment, according to Valuespectrum.

Cash flow improves despite losses

SNDL's adjusted operating income returned to positive territory at CAD 5.2 million in the third quarter, compared with an adjusted operating loss of CAD 9.5 million a year earlier. That CAD 14.8 million improvement contrasts with an IFRS operating loss of CAD 48.3 million, which included a CAD 52.0 million non-cash goodwill impairment tied to Cannabis Operations, the release said.

Free cash flow rose 19.5 percent from CAD 16.7 million in the third quarter of 2025. The company said CAD 10.6 million of the latest figure came from the initial unwinding of a captive insurance arrangement, making the cash result stronger than the operating improvement alone suggests.

Three dated steps shape the reset

On April 23, 2026, a United States regulatory order placed FDA-approved and qualifying state-regulated medical cannabis in Schedule III. On July 27, 2026, the restructuring of Parallel was completed, and SNDL's indirect equity interest later rose from 67 percent to 92 percent. On October 27, 2026, the company reported CAD 20.0 million of quarterly free cash flow and began its Cannabis Operations review, according to Valuespectrum.

What does the cannabis review change?

The review addresses the weakest operating area. Cannabis Operations revenue dropped 27.7 percent to CAD 27.0 million in the third quarter, while Cannabis Retail revenue increased 0.7 percent to CAD 85.6 million. SNDL said cost reductions at its Kelowna facility should begin contributing in the fourth quarter.

TipRanks reported on October 27, 2026 that the latest analyst view was a Buy rating with a USD 3.50 price target. The same report identified revenue contraction and margin pressure as counterweights to SNDL's liquidity, buybacks and positive adjusted operating income, according to TipRanks.

Reporting dates and capital returns

SNDL held its third-quarter earnings call on October 27, 2026, at 10:00 a.m. EDT. The company expects its share repurchase program to expire on November 20, 2026, after which it plans to seek renewal subject to board approval, according to Valuespectrum.

Stock price and valuation context

SNDL was trading at EUR 1.15 at Lang & Schwarz on October 27, 2026 at 2:17 p.m. CEST. The primary Nasdaq listing had closed at USD 1.27 on October 26, 2026 at 4:00 p.m. ET, while market capitalization stood at USD 312.6 million. The reported 52-week Nasdaq range was USD 1.13 to USD 2.34 as of October 26, 2026.

The further course of trading is shown by the continuously updated real-time quote of SNDL stock.